HC Wainwright & Co. Reiterates Buy on Rockwell Medical, Maintains $11 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a 'Buy' rating on Rockwell Medical (NASDAQ:RMTI) and maintained a price target of $11.
August 15, 2023 | 10:56 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Rockwell Medical's stock rating has been reiterated as 'Buy' by HC Wainwright & Co. with a maintained price target of $11.
The reiteration of a 'Buy' rating by a reputable analyst firm like HC Wainwright & Co. is a positive signal for investors. The maintained price target of $11 indicates the firm's continued confidence in the company's potential. This could lead to increased investor confidence and potentially a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100